Chronic lymphocytic leukemic patients, resistant to chemotherapy
- 1 August 1988
- journal article
- research article
- Published by Elsevier in Medical Hypotheses
- Vol. 26 (4) , 227-228
- https://doi.org/10.1016/0306-9877(88)90123-5
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Treatment of chronic lymphocytic leukemia using chlorambucil and prednisone with or without cycle-active consolidation chemotherapy .A southeastern cancer study group trialCancer, 1986
- Treatment of chronic lymphocytic leukemia in advanced stages. A randomized trial comparing chlorambucil plus prednisone versus cyclophosphamide, vincristine, and prednisoneCancer, 1985
- COMBINATION CHEMOTHERAPY OF ADVANCED CHRONIC LYMPHOCYTIC-LEUKEMIA - THE M-2 PROTOCOL (VINCRISTINE, BCNU, CYCLOPHOSPHAMIDE, MELPHALAN, AND PREDNISONE)1982
- Comparison of daily versus intermittent chlorambucil and prednisone therapy in the treatment of patients with chronic lymphocytic leukemiaBlood, 1977
- COMPARISON OF DAILY VERSUS INTERMITTENT CHLORAMBUCIL AND PREDNISONE THERAPY IN TREATMENT OF PATIENTS WITH CHRONIC LYMPHOCYTIC-LEUKEMIA1977
- Clinical staging of chronic lymphocytic leukemiaBlood, 1975
- Clinical Evaluation of an in Vitro Test for Radiosensitivity of Leukemic LymphocytesBlood, 1962
- Variability of the In Vitro Sensitivity of Human Leukemic Lymphocytes to X Rays and Chemotherapeutic Agents2JNCI Journal of the National Cancer Institute, 1958